Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01873573 · ClinicalTrials.gov registry record · NA
Randomized Controlled Trial of Endoscopic Dilation: Triamcinolone Injection
A NA study of Dysphagia, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT01873573 is a NA study of Dysphagia that has completed, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 10 participants, below the 172-participant average among 35 other Dysphagia trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01873573, a NA study of Dysphagia, has completed, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this pilot study is to find out if adding triamcinolone (steroid) injection at the participant's initial esophagogastroduodenoscopy (EGD) procedure will improve the opening of their esophagus and decrease the need for repeat dilations.
Conditions Studied
Interventions
- PROCEDURE Dilation
- OTHER Triamcinolone Injection
- PROCEDURE Esophagogastroduodenoscopy (EGD)
Study Locations (1)
Florida
- H. Lee Moffitt Cancer Center and Research Institute - Tampa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2013-07-18 |
| Est. Completion | 2017-10-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01873573
The ClinicalTrials.gov registry entry for NCT01873573 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 172-participant average among 35 other Dysphagia trials with a reported enrollment target (94% lower). The listed sponsor is H. Lee Moffitt Cancer Center and Research Institute, which has 502 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Dysphagia appearing as the primary indexed condition, and to 3 interventions - of which Dilation is the first listed.
NCT01873573 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT01873573 about?
NCT01873573 is a clinical study titled "Randomized Controlled Trial of Endoscopic Dilation: Triamcinolone Injection". The purpose of this pilot study is to find out if adding triamcinolone (steroid) injection at the participant's initial esophagogastroduodenoscopy (EGD) procedure will improve the opening of their esophagus and decrease the need for repeat dilations.
What is the current status of trial NCT01873573?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2013-07-18. Estimated completion is 2017-10-16.
What conditions does trial NCT01873573 study?
This clinical trial studies the following conditions: Dysphagia.
What interventions are being tested in trial NCT01873573?
The interventions under investigation include: Dilation (PROCEDURE), Triamcinolone Injection (OTHER), Esophagogastroduodenoscopy (EGD) (PROCEDURE).
Who is sponsoring clinical trial NCT01873573?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01873573 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dysphagia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Dissemination and Implementation of DIGEST™ as an Evidence-based Measurement Tool for Dysphagia: A Randomized Implementation Trial
RECRUITING · NA
-
Effect of Thickened Feeds on Swallow Physiology in Children With Dysphagia
RECRUITING · NA
-
Velopharyngeal Dysfunction in Head & Neck Cancer Patients, Pilot Study
RECRUITING · NA
-
Evolution of the Chicago Classification: Bridging Physiology and Mechanics
RECRUITING · NA
-
External Pharyngeal Exerciser and Pharyngeal Phase of Swallowing
RECRUITING · NA
-
The Esophageal String Test as a Diagnostic Screening Tool for Eosinophilic Esophagitis Among Africans With Dysphagia in Mali and the United States
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.